MC
NMTC icon

Mayo Clinic’s NeuroOne Medical Technologies NMTC Stock Holding History

Mayo Clinic’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,292
Closed -$145K – 4
2024
Q2 		$145K Hold
30,292
– – 4.8% 4
2024
Q1 		$218K Hold
30,292
– – 3.55% 4
2023
Q4 		$287K Hold
30,292
– – 1.77% 4
2023
Q3 		$162K Hold
30,292
– – 0.31% 7
2023
Q2 		$218K Hold
30,292
– – 0.22% 9
2023
Q1 		$293K Hold
30,292
– – 0.24% 8
2022
Q4 		$218K Buy
+30,292
New +$271K 0.12% 9
2021
Q2 		$1.21M Buy
+30,292
New +$1.28M 1.33% 6

Other funds holding NMTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Mayo Clinic's NMTC Position: Q3 2024 in Review

Mayo Clinic sold out of NeuroOne Medical Technologies (NMTC) in Q3 2024, closing a stake of 30,292 shares — an estimated $145K sold.

Mayo Clinic first reported a position in NMTC in Q2 2021 and held it in 8 quarters. The position peaked at $1.21M in Q2 2021. 21 funds tracked by Wall St. Rank hold NMTC as of Q3 2024.

  • Mayo Clinic reported no remaining NeuroOne Medical Technologies position as of Q3 2024 after selling out during the quarter.
  • Mayo Clinic sold 30,292 NeuroOne Medical Technologies shares in Q3 2024, an estimated $145K.
  • Mayo Clinic first reported a position in NeuroOne Medical Technologies in Q2 2021 and held it in 8 quarters.
  • Mayo Clinic's NeuroOne Medical Technologies position peaked at $1.21M in Q2 2021.
  • 21 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2024.

Based on Mayo Clinic's 13F filing for Q3 2024, filed 12 Nov 2024.